Sedation by Dexmedetomidine and Propofol
- Registration Number
- NCT02993718
- Lead Sponsor
- Seoul National University Bundang Hospital
- Brief Summary
Under the hypothesis that dexmedetomidine sedation would result in less upper airway obstruction, we evaluated the occurrence of upper airway collapse or the requirement of airway intervention in patients with obstructive sleep apnea during dexmedetomidine or propofol sedation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 52
Inclusion Criteria
- Surgery under spinal anesthesia
- Intraoperative sedation
- American Society of Anesthesiology physical status 1 or 2
- Apnea/hypopnea index 5-14/h in Watch-PAT 200 analysis
Read More
Exclusion Criteria
- Anatomical defects on upper respiratory tract
- Psychotic disorder
- Drug addition
- Alcohol addition
- body mass index ≥ 35 kg/m2
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Propofol Propofol Intraoperative sedation is performed by using propofol Dexmedetomidine Dexmedetomidine Intraoperative sedation is performed by using dexmedetomidine.
- Primary Outcome Measures
Name Time Method The occurrence of upper airway obstruction During the sedation period, an average of 3 hours. When end-tidal carbon dioxide was not detected in spite of the respiratory effort during the sedation period, the case will be regarded as the occurrence of upper airway obstruction.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Seoul National University Bundang Hospital
🇰🇷Seongnam, Gyeonggi, Korea, Republic of